-
3661
Walk In or Get Out
Published 2017-07-01“…Department of Health and Human Services, Centers for Disease Control and Prevention, “ Disparities in HIV/AIDS, Viral Hepatitis, STDs and TB,” Last updated June 2013, https://www.cdc.gov/nchhstp/healthdisparities/africanamericans.html [iv] U.S. …”
Get full text
Article -
3662
Correlação entre esplenomegalia e plaquetopenia na forma hepatoesplênica da esquistossomose mansônica Correlation between splenomegaly and thrombocytopenia in hepatosplenic schisto...
Published 2010-12-01“…Were included patients with the disease confirmed by pathologic diagnosis of liver biopsy performed during surgery, and excluded all patients who had a history of chronic alcoholism, viral hepatitis, clinical and laboratory evidence of hepatic or histopathological changescompatible with liver cirrhosis. …”
Get full text
Article -
3663
Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
Published 2019-10-01“…Recent studies have identified a genetic variant rs641738 near two genes encoding membrane bound O-acyltransferase domain-containing 7 (MBOAT7) and transmembrane channel-like 4 (TMC4) that associate with increased risk of non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), alcohol-related cirrhosis, and liver fibrosis in those infected with viral hepatitis (Buch et al., 2015; Mancina et al., 2016; Luukkonen et al., 2016; Thabet et al., 2016; Viitasalo et al., 2016; Krawczyk et al., 2017; Thabet et al., 2017). …”
Get full text
Article -
3664
Systematic Assessment of Safety Threshold for Donor Age in Cadaveric Liver Transplantation
Published 2021-03-01“…The risk of GF was increased in subgroups with fewer LT cases, longer cold ischemic time, fewer male donors, and recipients with viral hepatitis (P < 0.05).Conclusion: Donor age might affect post-LT outcomes in a dose-dependent manner. …”
Get full text
Article -
3665
The Evolution of Hepatitis C Treatment
Published 2018-10-01“…It seems that HCV will emerge as the leading cause of viral hepatitis-related advanced liver diseases and death in the near future. …”
Get full text
Article -
3666
-
3667
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan
Published 2021-04-01“…Abstract The spreading of viral hepatitis among injecting drug users (IDU) is an emerging public health concern. …”
Get full text
Article -
3668
O-2 ROLE OF IMMUNE CHECKPOINTS AND ACTIVATED HELPER AND CYTOTOXIC T-CELLS IN DRUG-INDUCED LIVER INJURY (DILI)
Published 2021-09-01“…Methods: Blood samples were collected from adjudicated DILI (n=12) and viral hepatitis (VH, 13) at day 1 (recognition), 7 and >30. …”
Get full text
Article -
3669
O-3 TRENDS IN DECEASED DONOR AND LIVING DONOR LIVER TRANSPLANTATION IN LATIN AMERICAN COUNTRIES DURING A DECADE (2010-2019) . THE ALEH SPECIAL INTEREST GROUP, INTERNATIONAL SURVEY...
Published 2021-09-01“…Methods: This prospective cohort study included patients with HCV-related cirrhosis treated with DAAs and followed for at least 24 weeks after therapy at the Viral Hepatitis Outpatient Clinic of Hospital de Clinicas de Porto Alegre, Brazil, between August 2016 and November 2017. …”
Get full text
Article -
3670
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial
Published 2017-11-01“…Funding: National Research Agency on AIDS and Viral Hepatitis (ANRS).…”
Get full text
Article -
3671
-
3672
-
3673
-
3674
Decoding m6A mRNA methylation by reader proteins in liver diseases
Published 2024-03-01“…In this review, we introduce m6A readers, summarize the recognition and regulatory mechanisms of m6A readers on mRNA, and focus on the biological functions and mechanisms of m6A readers in liver cancer, viral hepatitis, non-alcoholic fatty liver disease (NAFLD), hepatic fibrosis (HF), acute liver injury (ALI), and other liver diseases. …”
Get full text
Article -
3675
-
3676
-
3677
The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study
Published 2023-12-01“…In particular, cirrhotic patients with viral hepatitis with/without alcohol consumption showed poor prognosis compared to other aetiologies. …”
Get full text
Article -
3678
Novel role of UHRF1 in the epigenetic repression of the latent HIV-1
Published 2022-05-01“…-FNRS, Belgium), the « Fondation Roi Baudouin », the NEAT (European AIDS Treatment Network) program, the Internationale Brachet Stiftung, ViiV Healthcare, the Télévie, the Walloon Region (« Fonds de Maturation »), « Les Amis des Instituts Pasteur à Bruxelles, asbl », the University of Brussels (Action de Recherche Concertée ULB grant), the Marie Skodowska Curie COFUND action European Union's Horizon 2020 research and innovation program under grant agreement No 691119-EU4HIVCURE-H2020-MSCA-RISE-2015, the French Agency for Research on AIDS and Viral Hepatitis (ANRS), the Sidaction and the “Alsace contre le Cancer” Foundation. …”
Get full text
Article -
3679
Generation of WAe001-A-15, a human embryonic stem cell line with miR-122 doxycycline-inducible expression
Published 2018-05-01“…Previous studies have demonstrated that miR-122 is a valuable therapeutic target for liver diseases, including viral hepatitis, fibrosis, steatosis, and hepatocarcinoma. …”
Get full text
Article -
3680
Animal models for HCV and HBV studies
Published 2007-02-01“…</span></p> <p class="MsoNormal"><span style="font-size: 10pt; font-family: QuorumITCbyBT-Book">Despite decades of intensive research and significant progresses in understanding of viral hepatitis, many basic questions and clinical problems still await to be resolved. …”
Get full text
Article